Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jane Robertson
AstraZeneca
Study Director - Tracy Batchelor, MD, MPH
Massachusetts General Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
62 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Camperdown, Australia
- Research Site
Heidelberg, Australia
- Research Site
Nedlands, Australia
- Research Site
Parkville, Australia
- Research Site
St Leonards, Australia
- Research Site
Woodville, Australia
- Research Site
Graz, Austria
- Research Site
Brussels (Anderlecht), Belgium
- Research Site
Brussels (Jette), Belgium
- Research Site
Brussels (Woluwé-St-Lambert), Belgium
- Research Site
Leuven, Belgium
- Research Site
Calgary, Alberta, Canada
- Research Site
Toronto, Ontario, Canada
- Research Site
Montreal, Quebec, Canada
- Research Site
Liberec, Czechia
- Research Site
Bobigny, France
- Research Site
Marseille, France
- Research Site
Paris, France
- Research Site
Rennes, France
- Research Site
Saint-Herblain, France
- Research Site
Villejuif, France
- Research Site
Berlin, Germany
- Research Site
Bielefeld, Germany
- Research Site
Dresden, Germany
- Research Site
Düsseldorf, Germany
- Research Site
Göttingen, Germany
- Research Site
Hanover, Germany
- Research Site
Heidelberg, Germany
- Research Site
Kiel, Germany
- Research Site
Leipzig, Germany
- Research Site
Nordhausen, Germany
- Research Site
Regensburg, Germany
- Research Site
Amsterdam, Netherlands
- Research Site
Groningen, Netherlands
- Research Site
Maastricht, Netherlands
- Research Site
Rotterdam, Netherlands
- Research Site
The Hague, Netherlands
- Research Site
Glasgow, United Kingdom
- Research Site
London, United Kingdom
- Research Site
Manchester, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2008
- Primary completion
- 30 Apr 2010
- Completion
- 30 Sept 2016
- Last update posted
- 28 Dec 2016
- Registered enrollment
- 423
- Registry id
- NCT00777153
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.